name,category,termsCCAAT/enhancer binding protein (C/EBP), delta,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010528$IPR011700:Basic leucine zipper, 450014789$IPR016468:CCAAT/enhancer-binding]
CCAAT/enhancer binding protein (C/EBP), delta,PIR_SUPERFAMILY[630005805$PIRSF005879:CCAAT/enhancer-binding, 630005806$PIRSF005879:CCAAT/enhancer-binding protein]
CCAAT/enhancer binding protein (C/EBP), delta,SMART[760000306$SM00338:BRLZ]
CCAAT/enhancer binding protein (C/EBP), delta,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000811$isopeptide bond, 790000852$leucine zipper, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
CCAAT/enhancer binding protein (C/EBP), delta,UP_SEQ_FEATURE[850010081$chain:CCAAT/enhancer-binding protein delta, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant]
F-box and leucine-rich repeat protein 6,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450001603$IPR001810:Cyclin-like F-box, 450011745$IPR013101:Leucine-rich repeat 2]
F-box and leucine-rich repeat protein 6,PIR_SUPERFAMILY[630028327$PIRSF036848:conserved protein with F-box/LRR-repeat, Skp2 type]
F-box and leucine-rich repeat protein 6,SMART[760000228$SM00256:FBOX]
F-box and leucine-rich repeat protein 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001304$repeat, 790001593$ubl conjugation pathway]
F-box and leucine-rich repeat protein 6,UP_SEQ_FEATURE[850018802$chain:F-box/LRR-repeat protein 6, 850103725$domain:F-box, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850118574$splice variant]
LY6/PLAUR domain containing 3,INTERPRO[450001358$IPR001526:CD59 antigen, 450014439$IPR016054:Ly-6 antigen / uPA receptor -like, 450016648$IPR018363:CD59 antigen, conserved site]
LY6/PLAUR domain containing 3,SMART[760000116$SM00134:LU]
LY6/PLAUR domain containing 3,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001304$repeat, 790001405$signal]
LY6/PLAUR domain containing 3,UP_SEQ_FEATURE[850029210$chain:Ly6/PLAUR domain-containing protein 3, 850105610$domain:UPAR/Ly6 1, 850105611$domain:UPAR/Ly6 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105859$lipid moiety-binding region:GPI-anchor amidated cysteine, 850109701$propeptide:Removed in mature form, 850117814$signal peptide]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,INTERPRO[450002839$IPR003231:Acyl carrier protein (ACP), 450005594$IPR006162:Phosphopantetheine attachment site, 450005595$IPR006163:Phosphopantetheine-binding, 450008211$IPR009081:Acyl carrier protein-like]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,OMIM_DISEASE[520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,PIR_SUPERFAMILY[630002827$PIRSF002734:acyl/peptidyl carrier protein]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000249$carrier protein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000489$electron transport, 790000542$Fatty acid biosynthesis, 790000874$lipid synthesis, 790000969$mitochondrion, 790001006$nad, 790001092$oxidoreductase, 790001161$Phosphopantetheine, 790001162$phosphoprotein, 790001309$respiratory chain, 790001550$transit peptide, 790001558$transport]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,UP_SEQ_FEATURE[850003704$chain:Acyl carrier protein, mitochondrial, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118617$transit peptide:Mitochondrion, 850118624$turn]
NIMA (never in mitosis gene a)-related kinase 4,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
NIMA (never in mitosis gene a)-related kinase 4,SMART[760000193$SM00220:S_TKc]
NIMA (never in mitosis gene a)-related kinase 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790000973$mitosis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
NIMA (never in mitosis gene a)-related kinase 4,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059871$chain:Serine/threonine-protein kinase Nek4, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
PML-RARA regulated adaptor molecule 1,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450010373$IPR011511:Variant SH3]
PML-RARA regulated adaptor molecule 1,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
PML-RARA regulated adaptor molecule 1,SMART[760000295$SM00326:SH3]
PML-RARA regulated adaptor molecule 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000876$lipid-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain]
PML-RARA regulated adaptor molecule 1,UP_SEQ_FEATURE[850039620$chain:PML-RARA-regulated adapter molecule 1, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850106258$modified residue, 850110690$region of interest:8 X 12 AA repeats of K-P-P-[PQ]-P-[EQ]- [VAF]-T-D-L-P-K, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SRY (sex determining region Y)-box 9,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
SRY (sex determining region Y)-box 9,OMIM_DISEASE[520000092$Acampomelic campomelic dysplasia, 520000736$Campomelic dysplasia, 520000737$Campomelic dysplasia with autosomal sex reversal]
SRY (sex determining region Y)-box 9,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
SRY (sex determining region Y)-box 9,UP_SEQ_FEATURE[850065337$chain:Transcription factor SOX-9, 850102501$compositionally biased region:Gln/Pro-rich, 850102580$compositionally biased region:Poly-Pro, 850102920$DNA-binding region:HMG box, 850105852$helix, 850117295$sequence variant, 850118575$strand]
allograft inflammatory factor 1,INTERPRO[450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
allograft inflammatory factor 1,OMIM_DISEASE[520002058$Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity]
allograft inflammatory factor 1,PIR_SUPERFAMILY[630027759$PIRSF036323:allograft inflammatory factor-1]
allograft inflammatory factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000019$actin-binding, 790000211$calcium, 790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000480$EF hand, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
allograft inflammatory factor 1,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850004554$chain:Allograft inflammatory factor 1, 850103572$domain:EF-hand 1, 850103584$domain:EF-hand 2; degenerate, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
ankyrin repeat domain 6,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 6,PIR_SUPERFAMILY[630002425$PIRSF002299:hypothetical protein DKFZp434E1335.1]
ankyrin repeat domain 6,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790000811$isopeptide bond, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation]
ankyrin repeat domain 6,UP_SEQ_FEATURE[850005413$chain:Ankyrin repeat domain-containing protein 6, 850102580$compositionally biased region:Poly-Pro, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 3 open reading frame 63,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 3 open reading frame 63,UP_SEQ_FEATURE[850074100$chain:Uncharacterized protein C3orf63, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cytochrome P450, family 2, subfamily U, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 2, subfamily U, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450007406$IPR008069:Cytochrome P450, E-class, group I, CYP2D-like, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 2, subfamily U, polypeptide 1,KEGG_PATHWAY[470038780$hsa00590:Arachidonic acid metabolism]
cytochrome P450, family 2, subfamily U, polypeptide 1,PIR_SUPERFAMILY[630000058$PIRSF000045:cytochrome P450 CYP2D6]
cytochrome P450, family 2, subfamily U, polypeptide 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001555$transmembrane]
cytochrome P450, family 2, subfamily U, polypeptide 1,UP_SEQ_FEATURE[850013754$chain:Cytochrome P450 2U1, 850106026$metal ion-binding site:Iron (heme axial ligand), 850118574$splice variant, 850118623$transmembrane region]
dehydrogenase/reductase (SDR family) member 9,COG_ONTOLOGY[90000073$General function prediction only]
dehydrogenase/reductase (SDR family) member 9,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
dehydrogenase/reductase (SDR family) member 9,KEGG_PATHWAY[470038801$hsa00830:Retinol metabolism]
dehydrogenase/reductase (SDR family) member 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790000959$microsome, 790001006$nad, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001405$signal]
dehydrogenase/reductase (SDR family) member 9,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850000555$binding site:Substrate, 850014729$chain:Dehydrogenase/reductase SDR family member 9, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
egf-like module containing, mucin-like, hormone receptor-like 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000174$IPR000203:GPS, 450000637$IPR000742:EGF-like, type 3, 450000724$IPR000832:GPCR, family 2, secretin-like, 450001543$IPR001740:GPCR, family 2, EMR1 hormone receptor, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016289$IPR017981:GPCR, family 2-like, 450016291$IPR017983:GPCR, family 2, secretin-like, conserved site, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
egf-like module containing, mucin-like, hormone receptor-like 1,PIR_SUPERFAMILY[630030187$PIRSF038685:EGF-like module-containing mucin-like hormone receptor-like 1, 630031208$PIRSF800007:secretin receptor-like G protein-coupled receptors]
egf-like module containing, mucin-like, hormone receptor-like 1,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000273$SM00303:GPS]
egf-like module containing, mucin-like, hormone receptor-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
egf-like module containing, mucin-like, hormone receptor-like 1,UP_SEQ_FEATURE[850016995$chain:EGF-like module-containing mucin-like hormone receptor-like 1, 850102600$compositionally biased region:Ser/Thr-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850103667$domain:EGF-like 3; calcium-binding, 850103687$domain:EGF-like 4; calcium-binding, 850103693$domain:EGF-like 5; calcium-binding, 850103696$domain:EGF-like 6; calcium-binding, 850104076$domain:GPS, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
epsin 3,INTERPRO[450000899$IPR001026:Epsin, N-terminal, 450003428$IPR003903:Ubiquitin interacting motif, 450008166$IPR008942:ENTH/VHS, 450012415$IPR013809:Epsin-like, N-terminal]
epsin 3,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
epsin 3,SMART[760000245$SM00273:ENTH, 760000632$SM00726:UIM]
epsin 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000876$lipid-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
epsin 3,UP_SEQ_FEATURE[850000483$binding site:Phosphatidylinositol lipid headgroup, 850017728$chain:Epsin-3, 850103717$domain:ENTH, 850106258$modified residue, 850110214$region of interest:3 X 3 AA repeats of N-P-F, 850110481$region of interest:5 X 3 AA repeats of [DE]-P-W, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850117162$repeat:UIM 1, 850117163$repeat:UIM 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
essential meiotic endonuclease 1 homolog 1 (S. pombe),INTERPRO[450005598$IPR006166:DNA repair nuclease, XPF-type/Helicase]
essential meiotic endonuclease 1 homolog 1 (S. pombe),KEGG_PATHWAY[470038825$hsa03440:Homologous recombination]
essential meiotic endonuclease 1 homolog 1 (S. pombe),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790000498$Endonuclease, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001049$nuclease, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
essential meiotic endonuclease 1 homolog 1 (S. pombe),UP_SEQ_FEATURE[850012709$chain:Crossover junction endonuclease EME1, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
inverted formin, FH2 and WH2 domain containing,INTERPRO[450002728$IPR003104:Actin-binding FH2 and DRF autoregulatory, 450002748$IPR003124:Actin-binding WH2, 450009531$IPR010472:Diaphanous FH3, 450009532$IPR010473:Diaphanous GTPase-binding, 450013218$IPR014768:GTPase-binding/formin homology 3, 450013867$IPR015425:Actin-binding FH2]
inverted formin, FH2 and WH2 domain containing,SMART[760000218$SM00246:WH2, 760000441$SM00498:FH2]
inverted formin, FH2 and WH2 domain containing,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism]
inverted formin, FH2 and WH2 domain containing,UP_SEQ_FEATURE[850026719$chain:Inverted formin-2, 850102565$compositionally biased region:Poly-Ala, 850102586$compositionally biased region:Pro-rich, 850103774$domain:FH2, 850104044$domain:GBD/FH3, 850105698$domain:WH2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
leucine rich repeat containing 4B,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003159$IPR003598:Immunoglobulin subtype 2, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold]
leucine rich repeat containing 4B,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000356$SM00408:IGc2]
leucine rich repeat containing 4B,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001405$signal, 790001475$synapse, 790001555$transmembrane]
leucine rich repeat containing 4B,UP_SEQ_FEATURE[850028408$chain:Leucine-rich repeat-containing protein 4B, 850102517$compositionally biased region:Gly-rich, 850102565$compositionally biased region:Poly-Ala, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
lysine (K)-specific demethylase 4B,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450002638$IPR002999:Tudor domain, 450002921$IPR003347:Transcription factor jumonji/aspartyl beta-hydroxylase, 450002923$IPR003349:Transcription factor jumonji, JmjN, 450011770$IPR013129:Transcription factor jumonji, 450017293$IPR019023:Lamin-B receptor of TUDOR domain, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
lysine (K)-specific demethylase 4B,SMART[760000221$SM00249:PHD, 760000302$SM00333:TUDOR, 760000485$SM00545:JmjN, 760000497$SM00558:JmjC]
lysine (K)-specific demethylase 4B,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000437$dioxygenase, 790000802$iron, 790000937$metal-binding, 790001065$nucleus, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
lysine (K)-specific demethylase 4B,UP_SEQ_FEATURE[850000225$binding site:Alpha-ketoglutarate, 850029304$chain:Lysine-specific demethylase 4B, 850102586$compositionally biased region:Pro-rich, 850104488$domain:JmjC, 850104489$domain:JmjN, 850105584$domain:Tudor 1, 850105585$domain:Tudor 2, 850106100$metal ion-binding site:Iron; catalytic, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
melanoma antigen family A, 11,INTERPRO[450001943$IPR002190:MAGE protein]
melanoma antigen family A, 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001579$tumor antigen]
melanoma antigen family A, 11,UP_SEQ_FEATURE[850031009$chain:Melanoma-associated antigen 11, 850104744$domain:MAGE, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
mitogen-activated protein kinase kinase kinase 7,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000153$h_il1rPathway:Signal transduction through IL1R, 30000180$h_mapkPathway:MAPKinase Signaling Pathway, 30000200$h_nfkbPathway:NF-kB Signaling Pathway, 30000210$h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae, 30000215$h_p38mapkPathway:p38 MAPK Signaling Pathway , 30000218$h_Par1Pathway:Thrombin signaling and protease-activated receptors, 30000293$h_tgfbPathway:TGF beta signaling pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway, 30000300$h_tollPathway:Toll-Like Receptor Pathway, 30000313$h_wntPathway:WNT Signaling Pathway]
mitogen-activated protein kinase kinase kinase 7,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014220$IPR015786:Mitogen activated protein kinase kinase kinase-related, 450015749$IPR017421:Mitogen-activated protein kinase kinase kinase 7, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
mitogen-activated protein kinase kinase kinase 7,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038846$hsa04310:Wnt signaling pathway, 470038856$hsa04520:Adherens junction, 470038862$hsa04620:Toll-like receptor signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway, 470038864$hsa04622:RIG-I-like receptor signaling pathway, 470038869$hsa04660:T cell receptor signaling pathway]
mitogen-activated protein kinase kinase kinase 7,PIR_SUPERFAMILY[630029782$PIRSF038168:MAPKKK7, 630029783$PIRSF038168:mitogen-activated protein kinase kinase kinase 7]
mitogen-activated protein kinase kinase kinase 7,SMART[760000192$SM00219:TyrKc]
mitogen-activated protein kinase kinase kinase 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001388$serine/threonine-protein kinase, 790001547$transferase]
mitogen-activated protein kinase kinase kinase 7,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850032114$chain:Mitogen-activated protein kinase kinase kinase 7, 850102581$compositionally biased region:Poly-Ser, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850118574$splice variant, 850118575$strand, 850118624$turn]
muscleblind-like 3 (Drosophila),INTERPRO[450000486$IPR000571:Zinc finger, CCCH-type]
muscleblind-like 3 (Drosophila),SMART[760000324$SM00356:ZnF_C3H1]
muscleblind-like 3 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
muscleblind-like 3 (Drosophila),UP_SEQ_FEATURE[850032845$chain:Muscleblind-like protein 3, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850118574$splice variant, 850118752$zinc finger region:C3H1-type 1, 850118753$zinc finger region:C3H1-type 2, 850118754$zinc finger region:C3H1-type 3, 850118756$zinc finger region:C3H1-type 4]
oncomodulin,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450007417$IPR008080:Parvalbumin, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
oncomodulin,PIR_SUPERFAMILY[630002471$PIRSF002352:parvalbumin]
oncomodulin,SMART[760000046$SM00054:EFh]
oncomodulin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000473$duplication, 790000480$EF hand, 790001189$placenta, 790001212$polymorphism, 790001304$repeat, 790001578$tumor]
oncomodulin,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850036099$chain:Oncomodulin, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
phosphatidylglycerophosphate synthase 1,COG_ONTOLOGY[90000084$Lipid metabolism]
phosphatidylglycerophosphate synthase 1,INTERPRO[450001539$IPR001736:Phospholipase D/Transphosphatidylase, 450014594$IPR016270:Phospholipase D, phosphatidylserine synthase type]
phosphatidylglycerophosphate synthase 1,KEGG_PATHWAY[470038778$hsa00564:Glycerophospholipid metabolism]
phosphatidylglycerophosphate synthase 1,PIR_SUPERFAMILY[630000984$PIRSF000850:phospholipase D, PSS type, 630000985$PIRSF000850:Phospholipase_D_PSS]
phosphatidylglycerophosphate synthase 1,SMART[760000137$SM00155:PLDc]
phosphatidylglycerophosphate synthase 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001156$phospholipid biosynthesis, 790001304$repeat, 790001547$transferase, 790001550$transit peptide]
phosphatidylglycerophosphate synthase 1,UP_SEQ_FEATURE[850010221$chain:CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial, 850105045$domain:PLD phosphodiesterase 1, 850105046$domain:PLD phosphodiesterase 2, 850106263$nucleotide phosphate-binding region:ATP, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
phosphatidylinositol glycan anchor biosynthesis, class O,INTERPRO[450002301$IPR002591:Type I phosphodiesterase/nucleotide pyrophosphatase/phosphate transferase, 450016171$IPR017849:Alkaline phosphatase-like, alpha/beta/alpha]
phosphatidylinositol glycan anchor biosynthesis, class O,KEGG_PATHWAY[470038777$hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis]
phosphatidylinositol glycan anchor biosynthesis, class O,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000629$gpi-anchor biosynthesis, 790000919$membrane, 790001212$polymorphism, 790001547$transferase, 790001555$transmembrane]
phosphatidylinositol glycan anchor biosynthesis, class O,UP_SEQ_FEATURE[850022298$chain:GPI ethanolamine phosphate transferase 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
phospholipase C, eta 1,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000792$IPR000909:Phospholipase C, phosphatidylinositol-specific , X region, 450001047$IPR001192:Phospholipase C, phosphoinositol-specific, C-terminal (PLC), 450001516$IPR001711:Phospholipase C, phosphatidylinositol-specific, Y domain, 450001635$IPR001849:Pleckstrin homology, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450010818$IPR011993:Pleckstrin homology-type, 450013800$IPR015359:Phospholipase C, phosphoinositol-specific, EF-hand-like, 450016257$IPR017946:PLC-like phosphodiesterase, TIM beta/alpha-barrel domain, 450016334$IPR018029:C2 membrane targeting protein, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
phospholipase C, eta 1,SMART[760000046$SM00054:EFh, 760000130$SM00148:PLCXc, 760000131$SM00149:PLCYc, 760000205$SM00233:PH, 760000211$SM00239:C2]
phospholipase C, eta 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000869$lipid degradation, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001304$repeat, 790001546$transducer]
phospholipase C, eta 1,UP_SEQ_FEATURE[850000555$binding site:Substrate, 850000789$chain:1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase eta-1, 850102581$compositionally biased region:Poly-Ser, 850103199$domain:C2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850104979$domain:PH, 850104990$domain:PI-PLC X-box, 850104991$domain:PI-PLC Y-box, 850105913$metal ion-binding site:Calcium 1; catalytic, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850105925$metal ion-binding site:Calcium 3, 850105927$metal ion-binding site:Calcium 3; via carbonyl oxygen, 850106258$modified residue, 850118574$splice variant]
phytanoyl-CoA dioxygenase domain containing 1,INTERPRO[450008026$IPR008775:Phytanoyl-CoA dioxygenase]
phytanoyl-CoA dioxygenase domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000437$dioxygenase, 790000802$iron, 790000937$metal-binding, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism]
phytanoyl-CoA dioxygenase domain containing 1,UP_SEQ_FEATURE[850000225$binding site:Alpha-ketoglutarate, 850039105$chain:Phytanoyl-CoA dioxygenase domain- containing protein 1, 850105852$helix, 850106003$metal ion-binding site:Iron, 850106258$modified residue, 850110916$region of interest:Alpha-ketoglutarate binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
poly(A) binding protein interacting protein 2,INTERPRO[450008904$IPR009818:Ataxin-2, C-terminal]
poly(A) binding protein interacting protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001551$translation regulation]
poly(A) binding protein interacting protein 2,UP_SEQ_FEATURE[850039794$chain:Polyadenylate-binding protein-interacting protein 2, 850102507$compositionally biased region:Glu-rich, 850113865$region of interest:PABPC1-interacting motif-1 (PAM1), 850113866$region of interest:PABPC1-interacting motif-2 (PAM2), 850117294$sequence conflict, 850118624$turn]
solute carrier family 22 (organic cation transporter), member 1,COG_ONTOLOGY[90000018$Carbohydrate transport and metabolism / Amino acid transport and metabolism / Inorganic ion transport and metabolism / General function prediction only]
solute carrier family 22 (organic cation transporter), member 1,INTERPRO[450004237$IPR004749:Organic cation transport protein, 450005276$IPR005829:Sugar transporter, conserved site, 450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 22 (organic cation transporter), member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
solute carrier family 22 (organic cation transporter), member 1,UP_SEQ_FEATURE[850061385$chain:Solute carrier family 22 member 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850118355$site:Involved in affinity and selectivity of cations as well as in translocation, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
transmembrane protein 25,INTERPRO[450006486$IPR007110:Immunoglobulin-like, 450011799$IPR013162:CD80-like, immunoglobulin C2-set]
transmembrane protein 25,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
transmembrane protein 25,UP_SEQ_FEATURE[850066160$chain:Transmembrane protein 25, 850102883$disulfide bond, 850104199$domain:Ig-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
tripartite motif-containing 36,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001628$IPR001841:Zinc finger, RING-type, 450001654$IPR001870:B302 (SPRY)-like, 450003406$IPR003879:Butyrophylin-like, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold, 450016218$IPR017903:COS domain, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
tripartite motif-containing 36,SMART[760000051$SM00060:FN3, 760000158$SM00184:RING, 760000304$SM00336:BBOX]
tripartite motif-containing 36,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000410$cytoskeleton, 790000859$ligase, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
tripartite motif-containing 36,UP_SEQ_FEATURE[850016767$chain:E3 ubiquitin-protein ligase Trim36, 850103078$domain:B30.2/SPRY, 850103408$domain:COS, 850103799$domain:Fibronectin type-III, 850117295$sequence variant, 850118639$zinc finger region:B box-type 1, 850118642$zinc finger region:B box-type 2, 850118920$zinc finger region:RING-type; degenerate]
twisted gastrulation homolog 1 (Drosophila),INTERPRO[450006168$IPR006761:Twisted gastrulation (Tsg) protein]
twisted gastrulation homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
twisted gastrulation homolog 1 (Drosophila),UP_SEQ_FEATURE[850067301$chain:Twisted gastrulation protein homolog 1, 850102480$compositionally biased region:Cys-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
ubiquitin specific peptidase 6 (Tre-2 oncogene),INTERPRO[450000166$IPR000195:RabGAP/TBC, 450001239$IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, 450016487$IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site]
ubiquitin specific peptidase 6 (Tre-2 oncogene),SMART[760000143$SM00164:TBC]
ubiquitin specific peptidase 6 (Tre-2 oncogene),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001271$Proto-oncogene, 790001509$thiol protease, 790001593$ubl conjugation pathway]
ubiquitin specific peptidase 6 (Tre-2 oncogene),UP_SEQ_FEATURE[850067999$chain:Ubiquitin carboxyl-terminal hydrolase 6, 850105135$domain:Rab-GAP TBC, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
zinc finger, DHHC-type containing 19,INTERPRO[450001416$IPR001594:Zinc finger, DHHC-type]
zinc finger, DHHC-type containing 19,PIR_SUPERFAMILY[630029028$PIRSF037459:zinc finger DHHC domain-containing protein 7]
zinc finger, DHHC-type containing 19,SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001547$transferase, 790001555$transmembrane, 790001648$zinc, 790001651$zinc-finger]
zinc finger, DHHC-type containing 19,UP_SEQ_FEATURE[850043049$chain:Probable palmitoyltransferase ZDHHC19, 850117295$sequence variant, 850118623$transmembrane region, 850118801$zinc finger region:DHHC-type]
zinc finger, MYND-type containing 17,INTERPRO[450002557$IPR002893:Zinc finger, MYND-type]
zinc finger, MYND-type containing 17,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
zinc finger, MYND-type containing 17,UP_SEQ_FEATURE[850101425$chain:Zinc finger MYND domain-containing protein 17, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118853$zinc finger region:MYND-type]
